Back to search

United Kingdom· GB-APID-19180811000001109

Dipipanone 10mg / Cyclizine 30mg tablets

A medicinal product containing dipipanone + cyclizine, registered in United Kingdom by Advanz Pharma.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedDipipanone 10mg / Cyclizine 30mg tabl…ATC—REGISTER NO.GB-APID-1918081100000…PACKS LISTED1CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Dipipanone + Cyclizine
Manufacturer
Advanz Pharma
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5060337261272

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b103a89f-6bfe-45a9-81aa-cfee8647973e
GET /v1/drugs/b103a89f-6bfe-45a9-81aa-cfee8647973e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "19180811000001109",
  "desc": "Dipipanone 10mg / Cyclizine 30mg tablets (Advanz Pharma)",
  "form": "Oral tablet",
  "vpid": "39689711000001107",
  "source": "dmd",
  "vtm_id": "775412005",
  "strength": "30 mg",
  "substance": "Dipipanone + Cyclizine",
  "ingredient": "Cyclizine hydrochloride",
  "supplier_code": "24129411000001106"
}

See everything about dipipanone + cyclizine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.